Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Calcitonin (CT) is a known inhibitor of bone resorption. Calcitonin gene-related peptide-alpha (CGRPalpha), produced by alternative RNA processing of the CT/CGRP gene, has no clearly defined role in bone. To better understand the physiologic role of the CT/CGRP gene we created a mouse in which the coding sequences for both CT and CGRPalpha were deleted by homologous recombination. The CT/CGRP(-/-) knockout (KO) mice procreated normally, there were no identifiable developmental defects at birth, and they had normal baseline calcium-related chemistry values. However, KO animals were more responsive to exogenous human parathyroid hormone as evidenced by a greater increase of the serum calcium concentration and urine deoxypyridinoline crosslinks, an effect reversed by CT and mediated by a greater increase in bone resorption than in controls. Surprisingly, KO mice have significantly greater trabecular bone volume and a 1.5- to 2-fold increase in bone formation at 1 and 3 months of age. This effect appears to be mediated by increased bone formation. In addition, KO mice maintain bone mass following ovariectomy, whereas wild-type mice lose approximately one-third of their bone mass over 2 months. These findings argue for dual roles for CT/CGRP gene products: prevention of bone resorption in hypercalcemic states and a regulatory role in bone formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The phenotype of the Calca KO mice suggested that the osteoblast is the primary target of calcitonin/CGRP in bone and that calcitonin/CGRP inhibit bone formation.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The mice had no developmental defects and had normal baseline-circulating calcium levels.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“However, as the mice were deficient in both calcitonin and ␣CGRP, it was unclear which of the two peptides was responsible for the phenotype (97).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“Calca KO mice were less sensitive to OVX, maintaining their bone mass, whereas WT mice lost one-third of bone mass over 2 mo after OVX.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“Surprisingly, the Calca KO mice had significantly greater trabecular bone volume resulting from increased bone formation.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140 · cited 1×
“The immunoperoxidase analysis was performed on formalinfixed, paraffin-embedded tissues using the avidin-biotinperoxidase complex method (33).”
MethodParfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“A reinterpretation of these data based on the elucidation of the CGRPα/ RAMP receptor system (53, 54) suggests that CGRP at high concentrations cross-reacts with the CT receptor.”
MethodAmara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Evidence for Calcitonin—A New Hormone from the Parathyroid That Lowers Blood Calcium
COPP, D. H., CAMERON, E. C., CHENEY, B. A., DAVIDSON, A. G. F., & HENZE, K. G. (1962) · Endocrinology · doi:10.1210/endo-70-5-638 · Cited by 697 · cited 1×
“This substance was named calcitonin (CT) because it was presumed to play a role in regulating calcium metabolism (2).”
BackgroundAmling, M., Priemel, M., Holzmann, T., Chapin, K., Rueger, J. M., Baron, R., & Demay, M. B. (1999) · Endocrinology · doi:10.1210/endo.140.11.7110 · Cited by 499
Self-citationNicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 1×
“Since the discovery of CT, multiple studies have confirmed its hypocalcemic effect, which is mediated by the interaction of CT with a specific receptor on the osteoclast (10, 11).”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451 · cited 1×
“Since the discovery of CT, multiple studies have confirmed its hypocalcemic effect, which is mediated by the interaction of CT with a specific receptor on the osteoclast (10, 11).”
Background
Research works printed but not linked: 3
- Copp, 1961, Proc. Canad. Fed. Biol. Soc., 4, 17
- Singer, 1977, Clin. Orthop., 127, 86
- Becker, 1980, Arch. Pathol. Lab. Med., 104, 196
Cited by
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
“This is because its deletion yields a high bone mass rather than an osteopenic phenotyp”
BackgroundCalcium Absorption Across Epithelia
Hoenderop, J. G. J., Nilius, B., & Bindels, R. J. M. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2004 · Cited by 936
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765
“macrophage line, so the ability of CGRP to inhibit bone resorption/stimulate bone formation is probably related to a direct action on osteoclasts (149, 285).”
BackgroundOsteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Becker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Procalcitonin in bacterial infections - hype, hope, more or less?
Christ-Carin, M. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11169 · Cited by 367
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Lee, K. Y., & DeMayo, F. J. (2004) · Reproduction · doi:10.1530/rep.1.00340 · Cited by 284
Kovacs, C. S. (2014) · Physiological Reviews · doi:10.1152/physrev.00014.2014 · Cited by 258
“Ctcgrp null Calcitonin and calcitonin gene-related peptide- (119, 260, 430, 744)”
BackgroundJanssens, K., Vanhoenacker, F., Bonduelle, M., Verbruggen, L., Van Maldergem, L., Ralston, S., Guañabens, N., Migone, N., Wientroub, S., Divizia, M. T., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033522 · Cited by 244
Henriksen, K., Bollerslev, J., Everts, V., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 230
Salmon calcitonin: a review of current and future therapeutic indications
Chesnut, C. H., Azria, M., Silverman, S., Engelhardt, M., Olson, M., & Mindeholm, L. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0490-1 · Cited by 216
“orated [ 5 ], and no bone pathologies have been associated with hypo- or hypersecretion of calcitonin in humans [6].”
BackgroundKeller, J., Catala-Lehnen, P., Huebner, A. K., Jeschke, A., Heckt, T., Lueth, A., Krause, M., Koehne, T., Albers, J., Schulze, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6215 · Cited by 211
Self-citationBone remodelling: its local regulation and the emergence of bone fragility
Martin, T. J., & Seeman, E. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.07.006 · Cited by 203
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312135 · Cited by 206
Impaired gastric acidification negatively affects calcium homeostasis and bone mass
Schinke, T., Schilling, A. F., Baranowsky, A., Seitz, S., Marshall, R. P., Linn, T., Blaeker, M., Huebner, A. K., Schulz, A., Simon, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1963 · Cited by 205
“Biomechanical stability of the femora was determined by three-point bending assays as described, and maximum strength and overall stiffness of the vertebrae was determined by microcompression testin”
MethodSelf-citationCalcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during Lactation
Woodrow, J. P., Sharpe, C. J., Fudge, N. J., Hoff, A. O., Gagel, R. F., & Kovacs, C. S. (2006) · Endocrinology · doi:10.1210/en.2005-1616 · Cited by 195
Self-citationThe role of peptides and receptors of the calcitonin family in the regulation of bone metabolism
Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182
“These animals had high bone mass due to increased bone formation without changes in bone resorption, similar to the phenotype described initially for the CALCA-deficient mice [39].”
BackgroundResultOsteoclastogenesis, Bone Resorption, and Osteoclast-Based Therapeutics
Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E., & Huang, C. L.-H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.4.599 · Cited by 180
Decreased Bone Formation and Osteopenia in Mice Lacking α-Calcitonin Gene-Related Peptide
Schinke, T., Liese, S., Priemel, M., Haberland, M., Schilling, A. F., Catala-Lehnen, P., Blicharski, D., Rueger, J. M., Gagel, R. F., Emeson, R. B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040915 · Cited by 177
Self-citationMolecular and Cellular Mechanisms of Osteoporosis
Zhivodernikov, I. V., Kirichenko, T. V., Markina, Y. V., Postnov, A. Y., & Markin, A. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115772 · Cited by 166
Calcitonin, the forgotten hormone: does it deserve to be forgotten?
Felsenfeld, A. J., & Levine, B. S. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv011 · Cited by 174
“However, in a knockout mouse model in which the CT gene was deleted, no developmental defects were observed and procreation was normal [70].”
BackgroundThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“Similar to the phenotype described for the Calca-deficient mice (97), Calcr / mice had high bone mass caused by increased bone formation without changes in bone resorption (58).”
BackgroundResultMechanisms of Pain Modulation by Sex Hormones in Migraine
Gupta, S., McCarson, K. E., Welch, K. M. A., & Berman, N. E. J. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01908.x · Cited by 151
“are accentuated by estrogen pre-treatment in rats, and these responses are less pronounced in aged rats; this effect can be equalized to young rats by estrogen treatment.(126) Similarly, CGRP responses on blood pressure were more pronounced in pregnant rats and OVX rats treated with estrogen + progesterone.”
BackgroundYamaguchi, M., Watanabe, Y., Ohtani, T., Uezumi, A., Mikami, N., Nakamura, M., Sato, T., Ikawa, M., Hoshino, M., Tsuchida, K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.083 · Cited by 126
Eph Receptors and Ephrin Signaling Pathways: A Role in Bone Homeostasis
Edwards, C. M., & Mundy, G. R. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.263 · Cited by 122
“Calcitonin is well known to inhibit osteoclast function, however these mice display an increase in bone formation, an effect postulated to be the result of continuous osteoclast activation due to the calcitonin deficiency [77].”
BackgroundGooi, J. H., Pompolo, S., Karsdal, M. A., Kulkarni, N. H., Kalajzic, I., McAhren, S. H. M., Han, B., Onyia, J. E., Ho, P. W. M., Gillespie, M. T., et al. (2010) · Bone · doi:10.1016/j.bone.2010.02.018 · Cited by 117
“These observations indicate an inhibitory effect of calcitonin on bone formation, as in the other genetic studies [68, 71, 72, 74].”
BackgroundResultInfluentialRecent advances in physiological calcium homeostasis
Ramasamy, I. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.046 · Cited by 122
“(475) described an osteosclerotic phenotype in CT mice, and tetracycline labelling studies showed an increase in bone formation.”
BackgroundMabilleau, G., Mieczkowska, A., Irwin, N., Flatt, P. R., & Chappard, D. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0146 · Cited by 106
Wilkens, M. R., Nelson, C. D., Hernandez, L. L., & McArt, J. A. A. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-17268 · Cited by 128
Calcitonin: Physiology or fantasy?
Davey, R. A., & Findlay, D. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1869 · Cited by 101
“Indeed, CT/CGRPKO mice also showed a greater calcemic response to exogenous PTH administration than controls due to increased bone resorption, which was prevented by treatment with calcitonin but not CGRP.(30) Evidence from studies in global‐CTRKO and osteoclast‐CTRKOmice suggest that this effect of calcitonin to prot…”
BackgroundInfluentialThe critical interplay between bone resorbing and bone forming cells
Lerner, U. H., Kindstedt, E., & Lundberg, P. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13051 · Cited by 112
Increased Bone Formation in Mice Lacking Apolipoprotein E
Schilling, A. F., Schinke, T., Münch, C., Gebauer, M., Niemeier, A., Priemel, M., Streichert, T., Rueger, J. M., & Amling, M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041101 · Cited by 97
Self-citationMechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
Stepan, J. J., Alenfeld, F. E., Boivin, G., Feyen, J. H. M., & Lakatos, P. L. (2003) · PubMed · Cited by 113
Routine serum calcitonin measurement in the evaluation of thyroid nodules
Elisei, R. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.008 · Cited by 98
“It is known that CT specifically binds to the osteoclasts and that homozygous CT gene knock-out mice had a significant increase in bone formation, thus suggesting an inhibiting role of CT for bone resorption.(9,10) However, in normal human subjects even quite large amounts of circulating CT have no major impact on ser…”
BackgroundLerner, U. H., & Persson, E. (2008) · PubMed · Cited by 112
Calcitonin and bone formation: a knockout full of surprises
Zaidi, M., Moonga, B. S., & Abe, E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci17425 · Cited by 93
“(1) not only establishes a role for calcitonin in skeletal conservation, expected since its discovery four decades ago, but also opens new areas of investigation.”
BackgroundInfluentialBiological Basis of Bone Formation, Remodeling, and Repair—Part I: Biochemical Signaling Molecules
Allori, A. C., Sailon, A. M., & Warren, S. M. (2008) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2008.0082 · Cited by 117
“31,32 These findings indicate that calcitonin does more than prevent bone resorption during hypercalcemic states; rather, it serves a complicated regulatory role in bone formation and homeostasis.”
Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice
Davey, R. A., Turner, A. G., McManus, J. F., Chiu, W. M., Tjahyono, F., Moore, A. J., Atkins, G. J., Anderson, P. H., Ma, C., Glatt, V., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080310 · Cited by 87
Potential Role of Pancreatic and Enteric Hormones in Regulating Bone Turnover
Clowes, J. A., Khosla, S., & Eastell, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050524 · Cited by 87
Calcitonin Deficiency in Mice Progressively Results in High Bone Turnover
Huebner, A. K., Schinke, T., Priemel, M., Schilling, S., Schilling, A. F., Emeson, R. B., Rueger, J. M., & Amling, M. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060820 · Cited by 81
Self-citationOsteoclasts—Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0011-2015 · Cited by 86
“While early committed OC precursors express tartrate-resistant acid phosphatase (12) and α v β 5 integrin (13), late precursors and fully differentiated OCs upregulate cathepsin K (14, 15), calcitonin receptor (16), OC-associated receptor (OSCAR) (17), and α v β 3 integrin (18, 19).”
BackgroundCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
“introduced a mouse breed with decreased level of calcitonin and αCGRP due to absence of the required DNA sequences and were named as Calca knockout (KO) or CT/αCGRP [185].”
BackgroundInfluentialOsteoclastic differentiation and function regulated by old and new pathways
Blair, H. C., & Zaidi, M. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9010-4 · Cited by 82
“Further, in mouse models, deletion of calcitonin [39] or its receptor [20], do not reduce bone mass as expected.”
BackgroundThe role of calcitonin and α-calcitonin gene-related peptide in bone formation
Huebner, A. K., Keller, J., Catala-Lehnen, P., Perkovic, S., Streichert, T., Emeson, R. B., Amling, M., & Schinke, T. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.013 · Cited by 73
Self-citationIs Calcitonin an Important Physiological Substance?
Hirsch, P. F., & Baruch, H. (2003) · Endocrine · doi:10.1385/endo:21:3:201 · Cited by 73
Calcitonin, a Regulator of the 25-Hydroxyvitamin D3 1α-Hydroxylase Gene
Zhong, Y., Armbrecht, H. J., & Christakos, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806561200 · Cited by 67
Fudge, N. J., & Kovács, C. S. (2004) · BMC Physiology · doi:10.1186/1472-6793-4-5 · Cited by 68
“The role of calcitonin to minimize increases in the blood calcium in response to a calcium or PTH challenge has been demonstrated in mice lacking calcitonin through a genetic ablation [16]; and in rats rendered calcitonin deficient through surgical or immunological techniques [17,18].”
BackgroundImpaired osteoblast function in GPRC6A null mice
Pi, M., Zhang, L., Lei, S., Huang, M., Zhu, W., Zhang, J., Shen, H., Deng, H., & Quarles, L. D. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091037 · Cited by 70
“Indeed, several mouse models with a primary increase in osteoclast-mediated bone resorption, including OPG and calcitonin null mice,((9,10)) have a secondary increase in osteoblast-mediated bone formation.”
BackgroundThyroid C-Cell Biology and Oncogenic Transformation
Cote, G. J., Grubbs, E. G., & Hofmann, M.-C. C. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-22542-5_1 · Cited by 70
Self-citationDean, M. N., Ekstrom, L. J., Ornan, E. M., Ballantyne, J. C., Witten, P. E., Riley, C., Habraken, W. J. E. M., & Omelon, S. J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.022 · Cited by 68
Granholm, S., Lundberg, P., & Lerner, U. H. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0338 · Cited by 63
“…been challenged by the findings that mice deficient in the gene encoding CT, and the tissue-specific splice variant a -CGRP, do not exhibit decreased bone mass because of increased bone resorption, as expected, but instead theopposite,namelyincreasedbonemassduetoenhancedbone formation (Hoff et al .”
Muff, R., Born, W., Lutz, T. A., & Fischer, J. A. (2004) · Peptides · doi:10.1016/j.peptides.2004.08.007 · Cited by 62
Research progress in calcitonin gene-related peptide and bone repair
Wang, Q., Qin, H., Deng, J., Xu, H., Liu, S., Weng, J., & Zeng, H. (2023) · Biomolecules · doi:10.3390/biom13050838 · Cited by 58
“Hoff [122] 2002 Construction of CGRP knockout mouse model The bone mass of gene-knockout mice was maintained after ovariectomy, and that of gene-knockout wild-type mice decreased within two months.”
BackgroundInfluence of brain injury on early posttraumatic bone metabolism
Trentz, O. A., Handschin, A. E., Bestmann, L., Hoerstrup, S. P., Trentz, O., & Platz, A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000152221.87477.21 · Cited by 57
“Hoff (44) demonstrated that increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.”
BackgroundCalcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA?
Karsdal, M. A., Tankó, L. B., Riis, B. J., Søndergaard, B. C., Henriksen, K., Altman, R. D., Qvist, P., & Christiansen, C. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.03.014 · Cited by 64
Clarke, M. V., Russell, P. K., Findlay, D. M., Sastra, S., Anderson, P. H., Skinner, J. P., Atkins, G. J., Zajac, J. D., & Davey, R. A. (2015) · Endocrinology · doi:10.1210/en.2015-1345 · Cited by 54
“Specifically, the 2 intriguing actions of calcitonin identified in these studies are its actions to (1) inhibit bone formation (10, 11) by inhibiting the release of sphingosine 1-phosphate from osteoclasts (12) and (2) to protect the skeleton during calcium stress, in particular during hypercalcemia (13) mediated prim…”
BackgroundHsiao, C.-Y., Chen, T.-H., Chu, T.-H., Ting, Y.-N., Tsai, P., & Shyu, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00613 · Cited by 55
“The high bone mass attributed to increased bone formation has been found in both Calca KO and Calcr KO mice (7, 8), even though Calcr did not manifest in osteoblasts.”
BackgroundCurrent and future approaches using genetically modified mice in endocrine research
Davey, R. A., & MacLean, H. E. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2006 · Cited by 54
“This could include dietary manipulation, for example, by placing mice on a high-fat diet (25); altering hormonal status, such as by performing ovariectomy or orchidectomy (19); inducing metabolic stress through ischemia or other methods (49); or altering environmental factors, such as varying light-dark cycle length (…”
BackgroundGenetic determinants of bone mass
Baldock, P., & Eisman, J. A. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.moo.0000127828.34643.b4 · Cited by 58
Granholm, S., Henning, P., Lindholm, C., & Lerner, U. H. (2012) · Bone · doi:10.1016/j.bone.2012.09.019 · Cited by 49
“At first, we thought that expression of a functional CT receptor was a previously unrecognized phenotype of highly differentiated osteoblasts, which might explain why CT/α-CGRP−/− mice show increased bone mass due to increased bone formation rate [12].”
BackgroundEmerging neuroskeletal signalling pathways: a review
Spencer, G. J., Hitchcock, I. S., & Genever, P. G. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00053-5 · Cited by 53
McDonald, K. R., Fudge, N. J., Woodrow, J. P., Friel, J. K., Hoff, A. O., Gagel, R. F., & Kovacs, C. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00023.2004 · Cited by 51
“Furthermore, the skeletons were examined to determine whether the increased bone mass observed in adult Ct/Cgrp null mice (18) could be detected during fetal development.”
BackgroundMethodSelf-citationLowry, M. B., Guo, C., Borregaard, N., & Gombart, A. F. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.004 · Cited by 46
“CALCR is part of a feedback circuit induced by PTH that limits the bone resorbing activity of activated osteoclasts once calcium levels have increased [24].”
BackgroundProgesterone induction of calcitonin expression in the murine mammary gland
Ismail, P., DeMayo, F. J., Amato, P., & Lydon, J. P. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800287 · Cited by 48
“The foregoing speculations must be tempered, however, by the recent observation that the CT knockout (CTKO) mouse (Hoff et al. 2002) does not exhibit overt defects in fertility or mammary development; a knockout for CTR has yet to be reported.”
BackgroundcAMP/PKA Signaling Inhibits Osteogenic Differentiation and Bone Formation in Rodent Models
Siddappa, R., Mulder, W. R., Steeghs, I., van de Klundert, C., Fernandes, H., Liu, J., Arends, R. J., van Blitterswijk, C., & de Boer, J. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0512 · Cited by 55
“26,27 28–33 A recent study shows that constitutive over-expression of the G s - a subunit results in dramatic increase in bone formation, indicating the determinal role of GPCR signaling in bone formation.”
Lindfors, P. H., Lindahl, M., Rossi, J., Saarma, M., & Airaksinen, M. S. (2006) · Endocrinology · doi:10.1210/en.2005-1620 · Cited by 50
“For in vivo double calcein fluorescent labeling ( 13 , 14), mice were given two injections of calcein (25 mg/kg; Sigma, St. Louis, MO) 1 wk apart: first injection at P11 and second at P18.”
BackgroundMethodChia, L. Y., Walsh, N. C., Martin, T. J., & Sims, N. A. (2015) · Bone · doi:10.1016/j.bone.2014.11.005 · Cited by 42
“Calcitonin stimulates expression of sclerostin in young rats and mice [28], and this may mediate a role for calcitonin in inhibiting bone formation, indicated by studies in genetically altered mice [53,54].”
BackgroundCalcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure
Mai, T. H., Wu, J., Diedrich, A., Garland, E. M., & Robertson, D. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.03.001 · Cited by 43
Genetically Modified Animal Models as Tools for Studying Bone and Mineral Metabolism
Davey, R. A., MacLean, H. E., McManus, J. F., Findlay, D. M., & Zajac, J. D. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040206 · Cited by 40
Blair, H. C., Zaidi, M., Huang, C. L.-H., & Sun, L. (2008) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2008.00048.x · Cited by 48
“Its deletion in mice yields high bone mass rather than osteopenia (Zaidi, Moonga & Abe, 2002; Hoff et al., 2002).”
BackgroundTagariello, A., Heller, R., Greven, A., Kalscheuer, V. M., Molter, T., Rauch, A. M., Kress, W., & Winterpacht, A. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.037820 · Cited by 38
Calcitonin: Physiological Actions and Clinical Applications
Inzerillo, A. M., Zaidi, M., & Huang, C. L.-H. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.7.931 · Cited by 36
The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans
Boudin, E., Yorgan, T. A., Fijałkowski, I., Sonntag, S., Steenackers, E., Hendrickx, G., Peeters, S., Maré, A. D., Vervaet, B. A., Verhulst, A., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3160 · Cited by 33
“To assess biomechanical stability of the femurs, three-point bending assays were performed as described.((25,26))”
MethodCollins, J. N., Kirby, B. J., Woodrow, J. P., Gagel, R. F., Rosen, C. J., Sims, N. A., & Kovács, C. S. (2013) · Endocrinology · doi:10.1210/en.2012-1931 · Cited by 34
“difference in these parameters at baseline (28).”
BackgroundSelf-citationBecklund, B. R., Hansen, D. W., & DeLuca, H. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813312106 · Cited by 34
“For example, mice deficient in CT have normal serum calcium levels (19).”
BackgroundLi, J., Zhao, H., Supowit, S. C., DiPette, D. J., & Wang, D. H. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000125409.50839.f1 · Cited by 32
Amylin in the Periphery II: An Updated Mini-Review
Wookey, P. J., Lutz, T. A., & Andrikopoulos, S. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.263 · Cited by 32
“On the other hand, as found in the CT gene-deletion model[63] and in the CTR+/- haplo-insufficient strain[62], there is an increase in the rate of bone formation that seems to contradict previous findings on the role of CT/CTR in the activity of osteoclasts.”
ResultLian, J. B., & Stein, G. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088562-6/50015-7 · Cited by 33
G Protein and Its signaling pathway in bone development and disease
Wu, M., Deng, L., Zhu, G., & Li, Y.-P. (2010) · Frontiers in bioscience · doi:10.2741/3656 · Cited by 42
“High extracellular calcium concentration (3 to 5 mM) and the CaSR agonist neomycin inhibits 1,25 (OH)2D3- or human parathyroid hormone (hPTH) (1-34)induced osteoclast-like cell (Ocl) formation from osteoclast precursor cells derived from spleen cells (182).”
BackgroundInfluentialBaranowsky, A., Appelt, J., Kleber, C., Lange, T., Ludewig, P., Jahn, D., Pandey, P., Keller, D. B., Rose, T., Schetler, D., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004731 · Cited by 32
Self-citationKinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Köhler, O., Grünberg, W., Schnepel, N., Muscher‐Banse, A. S., Rajaeerad, A., Hummel, J., Breves, G., & Wilkens, M. R. (2020) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13449 · Cited by 31
In vivo impact of Dlx3 conditional inactivation in neural crest‐derived craniofacial bones
Duverger, O., Isaac, J., Zah, A., Hwang, J., Berdal, A., Lian, J. B., & Morasso, M. I. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24175 · Cited by 31
“…Nakamichi et al. (2003) — Increased Calca NM_001033954/ NM_007587 3.17 0.0429 Deletion of the calcitonin gene in mice leads to increased bone mass Hoff et al. (2002) Increased Increased Sost NM_024449 2.81 0.0119 Sclerostin knockout mice exhibit increased bone formation and mineral density Li…”
BackgroundInfluentialAlteration of parafollicular (C) cells activity in the experimental model of hypothyroidism in rats.
Zbucki, R. L., Winnicka, M. M., Sawicki, B., SZYNAKA, B., Andrzejewska, A., & Puchalski, Z. (2007) · PubMed · doi:10.5603/4541 · Cited by 29
Kuo, Y., Tsuang, F.-Y., Sun, J., Lin, C.-H., Chen, C.-H., Li, J.-Y., Huang, Y.-C., Chen, W., Yeh, C., & Shyu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040272 · Cited by 28
“However, it may also interfere with bone remodeling by inhibiting bone formation [16,17] although not markedly in humans [1].”
BackgroundKovács, C. S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382040-2.10011-5 · Cited by 30
Thyroid safety in patients treated with liraglutide
Gallo, M. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346749 · Cited by 27
“1%), produce Ct, a 32-amino-acid peptide hormone whose secretion is closely linked to calcium homeostasis in fishes and rodents, in which it seems to inhibit osteoclast-mediated bone resorption (18).”
BackgroundKauther, M. D., Neuerburg, C., Wefelnberg, F., Bachmann, H. S., Schlepper, R., Hilken, G., Broecker‐Preuss, M., Grabellus, F., Schilling, A. F., Jäger, M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.034 · Cited by 26
“A significant increase in bone formation and trabecular bone volumewas observed in young Calca / mice at the age of one to three months in comparison to their corresponding wild-type mice [4,5].”
BackgroundMethodStructural Biology of Calcitonin: From Aqueous Therapeutic Properties to Amyloid Aggregation
Kamgar‐Parsi, K., Tolchard, J. L., Habenstein, B., Loquet, A., Naito, A., & Ramamoorthy, A. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600096 · Cited by 26
Baranowsky, A., Jahn, D., Jiang, S., Yorgan, T. A., Ludewig, P., Appelt, J., Albrecht, K. K., Otto, E., Knapstein, P., Donat, A., et al. (2022) · Bone Research · doi:10.1038/s41413-021-00172-y · Cited by 25
“METHODS Mice Calca, αCgrp, and Calcr mice and WT control mice (all lines on a pure C57BL/6 J background) were genotyped as described.(25,34,51) For all in vivo experiments, 12-week-old female mice were used.”
MethodResultSelf-citationThe role of amylin and related peptides in osteoporosis
Bronský, J., Průša, R., & Nevoral, J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.05.009 · Cited by 26
Viney, T. J., Schmidt, T. W., Gierasch, W. W., Sattar, A. W., Yaggie, R. E., Kuburas, A., Quinn, J. P., Coulson, J. M., & Russo, A. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406659200 · Cited by 24
Procalcitonin and pneumonia: Is it a useful marker?
Christ‐Crain, M., & Müller-Stich, B. P. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0037-9 · Cited by 23
Decline in calcitonin receptor expression in osteocytes with age
Gooi, J. H., Chia, L. Y., Walsh, N. C., Karsdal, M. A., Quinn, J. M. W., Martin, T. J., & Sims, N. A. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0524 · Cited by 22
“Although a high level of bone formation was observed at 1 and 3 months of age (Hoff et al. 2002), the phenotype is dominated by increased resorption and cortical porosity in the long bones at 12 months of age (Huebner et al. 2006), presumably due to the lack of CT inhibitory action on osteoclasts.”
BackgroundCalcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis
Kauther, M. D., Bachmann, H. S., Neuerburg, L., Broecker-Preuss, M., Hilken, G., Grabellus, F., Koehler, G., von Knoch, M., & Wedemeyer, C. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-186 · Cited by 22
“Both alphaCGRP and calcitonin are generated by alternative splicing from the Calca gene, therefore we were interested in the outstanding phenotype of Calca deficient mice with an increased bone formation rate (BFR) in contrast to the decreased BFR in alpha-CGRP knockout mice [20,28].”
BackgroundResultInfluentialCalcitonin Physiology, Saved by a Lysophospholipid
Martin, T. J., & Sims, N. A. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2449 · Cited by 21
“Although the formation phenotype was predicted from the hypothesis, the fact that it was not evident at age 3 months contrasts with the Calca and Calcr mice, at which time increased bone mass and bone formation were very clearly evident, even as early as age 1 month in the Calca mice.((13)) Irrespective of this differ…”
BackgroundResultInfluentialCa2+-Dependent Regulation of Calcitonin Gene Expression by the Transcriptional Repressor DREAM
Matsuda, M., Yamamoto, T.-A., & Hirata, M. (2006) · Endocrinology · doi:10.1210/en.2006-0254 · Cited by 21
Hendrickx, G., Borra, V., Steenackers, E., Yorgan, T. A., Hermans, C., Boudin, E., Waterval, J. J., Jansen, I. D. C., Aydemir, T. B., Kamerling, N., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007321 · Cited by 22
Metadata
- Authors
- Hoff, A. O., Catala-Lehnen, P., Thomas, P. M., Priemel, M., Rueger, J. M., Nasonkin, I., Bradley, A., Hughes, M. R., Ordonez, N., Cote, G. J., Amling, M., & Gagel, R. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Universität Hamburg (DE)
- Baylor College of Medicine (US)
- Corresponding author
- Gagel, Robert F.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-12-15
- Volume
- 110
- Issue
- 12
- Pages
- 1849-1857
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC151647
- OpenAlex
- W2160364738
- Cited by
- 209
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 10 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 6
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk046660-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-46660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- calcitonin, calcitonin gene-related peptide, bone mass, bone resorption, bone formation, trabecular bone volume, parathyroid hormone response, hypercalcemia, ovariectomy, bone loss, deoxypyridinoline, calcium homeostasis
- MeSH terms
- Animals, Bone and Bones, Bone Resorption, Calcitonin, Estrogens, Female, Humans, Male, Mice, Inbred C57BL, Osteoclasts, Osteogenesis, Ovariectomy, Parathyroid Hormone, Phenotype, Radiography, Thyroid Gland, Bone Density, Calcitonin Gene-Related Peptide, Gene Deletion, Alternative Splicing, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.